Your session is about to expire
← Back to Search
CAMCI for Cognitive Impairment
Study Summary
This trial will help doctors to better identify and treat cognitive impairment, which can have a devastating effect on patients and their families.
- Cognitive Impairment
- Cognitive Decline
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are recruitment efforts currently underway for this research initiative?
"Affirmative, the data on clinicaltrials.gov indicate that this study is currently recruiting participants. This medical trial was initially posted on August 8th 2019 and underwent its most recent update on August 2nd 2022. Currently, they are admitting 820 patients across two different sites."
Does this medical research project accept me as a potential participant?
"This clinical trial is seeking 820 participants with cognitive decline in the senior age range of 60-95. To be eligible, applicants must fulfil several criteria including being within that age bracket and having the capacity to read and comprehend study materials as well as complete test requirements."
To what extent is this trial being utilized by research subjects?
"Correct. Clinicaltrials.gov shows that this medical trial, originally listed on August 8th 2019, is actively trying to recruit participants. This study requires 820 people from 2 different sites to be enrolled."
Does this trial permit individuals aged 30 years or older to enroll?
"The rulebook stipulates that the minimum age to join this experimental trial is 60 years old while the upper limit caps at 95."
Share this study with friends
Copy Link
Messenger